UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: CMImylan-10mg-Tablet-SE-IS-RA

Generated Narrative: RegulatedAuthorization CMImylan-10mg-Tablet-SE-IS-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/11339

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004079-00011339,http://ema.europa.eu/fhir/eurdId#811; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Egentlig depression med melankoli. Djupa eller långvariga egentliga depressioner utan melankoli. Paniksyndrom med eller utan agorafobi. Agorafobi. Tvångstillstånd. Associerade symtom vid narkolepsi (speciellt kataplexi, sömnparalys och hypnagoga hallucinationer). Idiopatiskt smärtsyndrom med depressiva symtom.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = N06AA04

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 1991-04-26

holder: Organization Mylan AB

Cases

-TypeDate[x]
*First Authorisation1991-04-26